BridgeMD
New treatment option for Endometriosis
Official title Developing a Complex ex Vivo Endometrial Tissue Model to Improve Endometriosis Care
ClinicalTrials.gov ID: NCT06331676
What this study is testing
- What it's testing
- Endometriosis is a chronic gynaecological disease characterised by the growth of endometrium outside the uterus. It affects 10% of childbearing age women.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 50, women only
You may be able to join if
- Female
- People aged between 18 and 50
- Person who has or has had hormonal contraceptive treatment
- A person who has given written consent
- Person diagnosed with a benign gynaecological pathology not affecting the endometrium and requiring hysterectomy, hysteroscopy or laparoscopy or with...
You likely can't join if
- Pregnant at the time of sampling or within 3 months prior to sampling
- Breast-feeding women
- Women undergoing physiological menopause
- Anyone who has received hormonal treatment with hormones other than steroids in the three months prior to sampling
- Anyone with a non-hormonal contraceptive intrauterine device (copper coil)
- Anyone with a personal history of cancer of the breast, ovary, endometrium or cervix
See the full eligibility criteria
- Female
- People aged between 18 and 50
- Person who has or has had hormonal contraceptive treatment
- A person who has given written consent
- Person diagnosed with a benign gynaecological pathology not affecting the endometrium and requiring hysterectomy, hysteroscopy or laparoscopy or with a diagnosis of endometriosis and requiring laparoscopy or hysterectomy
- Person affiliated to the french social security
- Pregnant at the time of sampling or within 3 months prior to sampling
- Breast-feeding women
- Women undergoing physiological menopause
- Anyone who has received hormonal treatment with hormones other than steroids in the three months prior to sampling
- Anyone with a non-hormonal contraceptive intrauterine device (copper coil)
- Anyone with a personal history of cancer of the breast, ovary, endometrium or cervix
- People with Lynch syndrome
- Persons under legal protection (guardianship, curatorship)
- Persons deprived of their liberty by judicial or administrative decision
- Persons with a body mass index (BMI) of less than 18.5 or more than 30
The study team makes the final eligibility decision.
Where it's taking place
- Bron, France
- Lyon, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18 years to 50 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Bron, France; Lyon, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.